|
Pimocard
|
2.5 mg
|
V/MRP/15/0061
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
flavoured tablets
|
| International name (active substance): |
Pimobendan
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dales Pharmaceuticals Ltd., Lielbritānija;Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
31-Jul-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 260122LI (26-Jan-2022)
|
| Labelling text: |
[PDF] 280717M (31-Jul-2017)
|
| Summary of product characteristics: |
[PDF] 280717ZA (31-Jul-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0061-01 |
2,5 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-02 |
2,5 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-03 |
2,5 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-04 |
2,5 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0061-05 |
2,5 mg |
2 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0061-06 |
2,5 mg |
5 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0061-07 |
2,5 mg |
10 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0061-08 |
2,5 mg |
25 |
Al/Al blisteris, 10 tablete |
-
|
|
|
Pimocard
|
10 mg
|
V/MRP/15/0063
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
flavoured tablets
|
| International name (active substance): |
Pimobendan
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande;Dales Pharmaceuticals Ltd., Lielbritānija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
31-Jul-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 260122LI (26-Jan-2022)
|
| Labelling text: |
[PDF] 280717M (31-Jul-2017)
|
| Summary of product characteristics: |
[PDF] 280717ZA (31-Jul-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0063-01 |
10 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-02 |
10 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-03 |
10 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-04 |
10 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0063-05 |
10 mg |
4 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0063-06 |
10 mg |
10 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0063-07 |
10 mg |
20 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0063-08 |
10 mg |
50 |
Al/Al blisteris, 5 tablete |
-
|
|
|
Pimocard
|
1.25 mg
|
V/MRP/15/0060
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
flavoured tablets
|
| International name (active substance): |
Pimobendan
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande;Dales Pharmaceuticals Ltd., Lielbritānija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
31-Jul-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 260122LI (26-Jan-2022)
|
| Labelling text: |
[PDF] 280717M (31-Jul-2017)
|
| Summary of product characteristics: |
[PDF] 280717ZA (31-Jul-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0060-01 |
1,25 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0060-02 |
1,25 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0060-03 |
1,25 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
[JPG]
|
| V/MRP/15/0060-04 |
1,25 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0060-05 |
1,25 mg |
2 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0060-06 |
1,25 mg |
5 |
Al/Al blisteris, 10 tablete |
-
|
| V/MRP/15/0060-07 |
1,25 mg |
10 |
Al/Al blisteris, 10 tablete |
[JPG]
|
| V/MRP/15/0060-08 |
1,25 mg |
25 |
Al/Al blisteris, 10 tablete |
-
|
|
|
Pimocard
|
5 mg
|
V/MRP/15/0062
|
Eurovet Animal Health B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
flavoured tablets
|
| International name (active substance): |
Pimobendan
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande;Dales Pharmaceuticals Ltd., Lielbritānija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
31-Jul-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 260122LI (26-Jan-2022)
|
| Labelling text: |
[PDF] 280717M (31-Jul-2017)
|
| Summary of product characteristics: |
[PDF] 280717ZA (31-Jul-2017)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/15/0062-01 |
5 mg |
2 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0062-02 |
5 mg |
5 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0062-03 |
5 mg |
10 |
PVH/PE/PVAc blisters, 10 tablete |
[JPG]
|
| V/MRP/15/0062-04 |
5 mg |
25 |
PVH/PE/PVAc blisters, 10 tablete |
-
|
| V/MRP/15/0062-05 |
5 mg |
4 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0062-06 |
5 mg |
10 |
Al/Al blisteris, 5 tablete |
[JPG]
|
| V/MRP/15/0062-07 |
5 mg |
20 |
Al/Al blisteris, 5 tablete |
-
|
| V/MRP/15/0062-08 |
5 mg |
50 |
Al/Al blisteris, 5 tablete |
-
|
|
|
Pimocard
|
3.5 mg/ml
|
V/DCP/19/0068
|
Dechra Regulatory B.V., Nīderlande
|
QC01CE90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for oral use
|
| International name (active substance): |
Pimobendan
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 240120LI (24-Jan-2020)
|
| Labelling text: |
[DOCX] 260722M (26-Jul-2022)
|
| Summary of product characteristics: |
[DOCX] 260722ZA (26-Jul-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0068-01 |
3,5 mg/ml |
1 |
PET pudele, 42 ml |
-
|
| V/DCP/19/0068-02 |
3,5 mg/ml |
1 |
PET pudele, 168 ml |
-
|
|